Behavioral Medicine in the Prevention and Treatment of Cardiovascular Disease

Behavior Modification

Volumn 27, Issue 1, 2003, Pages 3-25

  Graves, Kristi D ^a   Miller, Peter M ^b  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIORAL MEDICINE; CARDIOVASCULAR DISEASE; ETHNOLOGY; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HUMAN; LIFESTYLE; METHODOLOGY; PATIENT COMPLIANCE; PRIMARY PREVENTION; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; UNITED STATES;

BEHAVIORAL MEDICINE; CARDIOVASCULAR DISEASES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HEALTH BEHAVIOR; HUMANS; LIFE STYLE; PATIENT COMPLIANCE; PRIMARY PREVENTION; PROCESS ASSESSMENT (HEALTH CARE); RISK FACTORS; UNITED STATES;

EID: 0037267651     PISSN: 01454455     EISSN: None     Source Type: Journal    
DOI: 10.1177/0145445502238690     Document Type: Article

References (99)

1. Ades, P. A., Huang, D., & Weaver, S. O. (1992). Cardiac rehabilitation participation predicts lower rehospitalization costs. American Heart Journal, 123, 916-921.
2. Ades, P. A., Waldmann, M. L., Polk, D. M., & Coflesky J. T. (1992). Referral patterns and exercise response in the rehabilitation of female coronary patients aged greater than or equal to 62 years. American Journal of Cardiology, 69, 1422-1425.
3. Allan, R., & Scheidt, S. (2000). Heart and mind: The practice of cardiac psychology. Washington, DC: American Psychological Association (APA).
4. American Heart Association. (2001). 2001 heart and stroke statistical update. Dallas, TX: American Heart Association.
5. Appels, A., Hoppener, P., & Muldur, P. (1987). A questionnaire to assess premonitory symptoms of myocardial infarction. International Journal of Cardiology, 17, 15-24.
6. Ballenger, J. C., Davidson, J. R. T., Lecrubier, Y., Nutt, D. J., Roose, S. P., & Sheps, D. S. (2001). Consensus statement on depression, anxiety, and cardiovascular disease. Journal of Clinical Psychiatry, 62, 24-27.
7. Barefoot, J. C. (1991). Developments in the measurement of hostility. In H. S. Friedman (Ed), Hostility coping and health (pp. 13-32). Washington, DC: APA.
8. Beck, A., Mendelsohn, M., Mack, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
9. Bellg, A. J. (1998). Clinical cardiac psychology. In P. Camic & S. Knight (Eds.), Clinical hand-book of health psychology (pp. 53-98). Seattle, WA: Hogrefe & Huber.
10. Bellg, A. J., Rivkin, S., & Rosenson, R. S. (1997). Adherence to lipid-altering medications and lifestyle recommendations. In B. Rose (Ed.), Up to date in cardiovascular medicine (Vol. 5). Wellesley, MA: BDR.
11. Benson, H., Alexander, S., & Feldman, C. L. (1975). Decreased premature ventricular contractions through use of the relaxation response in patients with stable ischemic heart disease. Lancet, 2, 380-382.
12. Berkman, L. F., Carney, R., Blumenthal, J., Czakowski, S., Hosking, J., Jaffe, A., et al. (2000). Enhancing recovery in coronary heart disease patients (ENRICHD): Study design and methods. American Heart Journal, 139, 1-9.
13. Bracke, P. E., & Thoresen, C. E. (1996). Reducing Type A behavior patterns: A structured-group approach. In R. Allan and S. Scheidt (Eds.), Heart and mind: The practice of cardiac psychology (pp. 255-290). Washington, DC: APA.
14. Burke, L. E., Dunbar-Jacob, J. M., & Hill, M. N. (1997). Compliance with cardiovascular disease prevention strategies: A review of the research. Annals of Behavioral Medicine, 19, 239-263.
15. Burt, V. L., Culter, J. A., Higgins, M., Horan, M. J., Labarthe, D., Whelton, P., et al. (1995). Trends in the prevalence, awareness, treatment, and control of hypertension in the adult U.S. population. Data from the health examination surveys, 1960 to 1991. Hypertension, 26, 60-69.
16. Burt, V. L., Whelton, P., & Roccella, E. J. (1995). Prevalence of hypertension in the U.S. adult population. Hypertension, 25, 305-313.
17. Buss, A. H., & Durkee, A. (1957). An inventory for assessing different kinds of hostility. Journal of Counseling Psychology, 42, 155-162.
18. Carhart, R. L., & Ades, P. A. (1998). Gender differences in cardiac rehabilitation. Cardiology Clinics, 16, 37-43.
19. Carter, C. L., Key, J., Marsh, L., & Graves, K. (2001). Contemporary perspectives in tobacco cessation: What oncologists need to know. The Oncologist, 6, 496-505.
20. CDC. (1993). Smoking-attributable mortality and years of potential life lost—United States, 1990. Morbidity and Mortality Weekly Report, 42, 645-648.
21. CDC. (1996). Physical activity and health: A report of the Surgeon General executive summary. Retrieved from http://www.cdc.gov/nccdphp/sgr/summary.htm
22. CDC. (2001a). Physical activity and good nutrition: Essential elements to prevent chronic diseases and obesity. At-A-Glance. Retrieved from http://www.cdc.gov/nccdphp/dnpa/dnpaaag.htm
23. CDC. (2001b). Five leading causes of death, Unites States, 1998, all races, females. Retrieved from http://webapp.cdc.gov/sasweb/ncipc/leadcaus.html
24. Dale, L. C., Hurt, R. D., Offord, K. P., Lawson, G. M., Croghan, I. T., & Schroeder, D. R. (1995). High-dose nicotine patch therapy: Percentage of replacement and smoking cessation. Journal of the American Medical Association (JAMA), 274, 1353-1358.
25. Denollet, J. (1998). Personality and coronary heart disease: The Type-D Scale-16 (DS16). Annals of Behavioral Medicine, 20, 209-215.
26. Denollet, J., Sys, S. U., Stroobant, N., Gillebert, T. C., & Brutsaert, D. L. (1996). Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet, 347, 414-415.
27. DHHS. (2001a). Healthy People 2010-Conference edition. Retrieved from http://www.health. gov/healthypeople/Document/HTML/Volume1/12Heart.htm#_Toc490544220
28. DHHS. (2001b). ATP III guidelines at-a-glance quick desk reference (NIH Publication No. 01-3305). Washington, DC: Author?
29. Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., et al. (1998). Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA, 279, 1615-1622.
30. Dunbar-Jacob, J., Burke, L. E., & Puczynski, S. (1995). Clinical assessment and management of adherence to medical regimens. In P. Nicassio & T. Smith (Eds.), Managing chronic illness: A biopsychosocial perspective. Washington, DC: APA.
31. Engebretson, T. O., Clark, M. M., Niaura, R. S., Phillips, T., Albrecht, A., & Tilkemeier, P. (1999). Quality of life and anxiety in a phase II cardiac rehabilitation program. Medicine and Science in Sports and Exercise, 31, 216-223.
32. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Fox, B. J., Goldstein, M. G., et al. (2000). Treating tobacco use and dependence. In Clinical practice guideline. Rockville, MD: DHHS Public Health Service.
33. Flack, J. M., Novikov, S. V., & Ferrario, C. M. (1996). Benefits of adherence to antihypertensive drug therapy. The European Society of Cardiology, 17(Suppl. A), 16-20.
34. Frasure-Smith, N., Lesperance, F., & Talajic, M. (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA, 270, 1819-1825.
35. Friedman, M., & Rosenman, R. H. (1959). Association of specific overt behavior pattern with blood and cardiovascular findings: Blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. JAMA, 169, 1286-1296.
36. Friedman, M., Thoresen, C. E., Gill, J., Ulmer, D., Powell, L. H., Price, V. A., et al. (1986). Alteration of Type A behavior and its effect on cardiac recurrences in postmyocardial infarction patients: Summary results of the Recurrent Coronary Prevention Project. American Heart Journal, 112, 653-665.
37. Giese, M., Lackland, D. T., & Egan, B. M. (2001). The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control. Journal–South Carolina Medical Association, 97, 57-62.
38. Glanz, K. (1979). Dietitians'effectiveness and patient compliance with dietary regimens. Journal of the American Dietetic Association, 75, 631-636.
39. Goff, D. C., Nichaman, M. Z., Chan, W., Ramsey, D. J., Labarthe, D. R., & Ortiz, C. (1997). Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic Whites. The Corpus Christi Heart Project, 1988-1992. Circulation, 95, 1433-1440.
40. Goldman, L., Garber, A., Grover, S., & Hlatky, M. (1996). Twenty-seventh Bethesda conference: Matching the intensity of risk factor management with the hazard for coronary disease events: Task Force 6: Cost effectiveness of assessment and management of risk factors. Journal of the American College of Cardiology, 27, 1020-1030.
41. Gotto, A. M. (1997). Cholesterol management in theory and practice. Circulation, 96, 4424-4430.
42. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
43. Harlan, W. R., Sandler, S. A., Lee, K. L., Lam, L. C., & Mark, D. B. (1995). Importance of baseline functional and socioeconomic factors for participation in cardiac rehabilitation. American Journal of Cardiology, 76, 36-39.
44. Haskell, W. L., Alderman, E. L., Fair, J. M., Maron, D. J., Mackey, S. F., & Superko, R. H. (1994). Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation, 89, 975-990.
45. Iribarren, C., Sidney, S., Bild, D. E., Liu, K., Markovitz, J. H., Roseman, J. M., et al. (2000). Association of hostility with coronary artery calcification in young adults: The CARDIA study. Coronary Artery Risk Development in Young Adults. JAMA, 283, 2546-2551.
46. Johnston, L. D., O'Maley, P. M., & Bachman, J. G. (1999). The Monitoring the Future national survey results on adolescent drug use: Overview of key findings. Rockville, MD: National Institute on Drug Abuse.
47. Kawachi, I., Colditz, G. A., Asherio, A., Rimm, E. B., Giovannucci, E., Stampfer, M. J., et al. (1994). Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation, 89, 1992-1997.
48. Ketola, E., Sipila, R., & Makela, M. (2000). Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors. Annals of Medicine, 32, 239-251.
49. Ketterer, M. W., Mahr, G., & Goldberg, A. D. (2000). Psychological factors affecting a medical condition: Ischemic coronary heart disease. Journal of Psychosomatic Research, 48, 357-367.
50. Kiernan, M., Phillips, K., Fair, J. M., & King, A. C. (2000). Using direct mail to recruit Hispanic adults into a dietary intervention: An experimental study. Annals of Behavioral Medicine, 22, 89-93.
51. Kjellgren, K. I., Ahlner, J., & Saljo, R. (1995). Taking antihypertensive medications—or cooperating with patients? International Journal of Cardiology, 47, 257-268.
52. Ladwig, K. H., Roll, G., & Breithardt, G. (1994). Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet, 343, 20-23.
53. Lamarche, B., St.-Pierre, A. C., Ruel, I. L., Cantin, B., Dagenais, G. R., & Despres, J. P. (2001). A prospective, population-based study of low-density lipoprotein particle size as a risk factor for ischemic heart disease in men. Canadian Journal of Cardiology, 17, 859-865.
54. Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992). Cumulative meta-analysis of therapeutic trials for myocardial infarction. New England Journal of Medicine, 327, 248-254.
55. Levin, L. A., Perk, J., & Hedback, B. (1991). Cardiac rehabilitation—A cost analysis. Journal of Internal Medicine, 230, 427-434.
56. Lieberman, L., Meana, M., & Stewart, D. (1998). Cardiac rehabilitation: Gender differences in factors influencing participation. Journal of Women's Health, 7, 717-723.
57. Linden, W. (2000). Psychological treatments in cardiac rehabilitation: Review of rationales and outcomes. Journal of Psychosomatic Research, 48, 443-454.
58. McBride, P., Schrott, H. G., Plane, M. B., Underbakke, G., & Brown, R. L. (1998). Primary care practice adherence to national cholesterol education program guidelines for patients with coronary heart disease. Archives of Internal Medicine, 158, 1238-1244.
59. McHorney, C. A., & Ware, J. E. (1995). Construction and validation of an alternate form general mental health scale for the Medical Outcomes Study Short-Form 36–Item Health Survey. Medical Care, 33, 15-28.
60. Mosca, L., Grundy, S. M., Judelson, D., King, K., Limacher, M., Oparil, S., et al. (1999). AHA/ACC scientific statement: Consensus panel statement. Guide to preventive cardiology for women. Circulation, 99, 2480-2484.
61. Mosca, L., Manson, J. E., Sutherland, S. E., Lnager, R. D., Manolio, T., & Barrett-Connor, E. (1997). Cardiovascular disease in women: A statement for health care professionals from the American Heart Association: Writing group. Circulation, 96, 2468-2482.
62. Nagubandi, M. K., Sung, B. H., & Wilson, M. F. (2001). Effects of mental stress on large and small artery compliance. American Journal of Hypertension, 14, A129-129.
63. National Heart, Lung, and Blood Institute. (1998, October). Morbidity and mortality: 1998 chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: NIH Public Health Service.
64. Newell, S. A., Bowman, J. A., & Cockburn, J. D. (1999). A critical review of interventions to increase compliance with medication taking, obtaining medication refills, and appointment keeping in the treatment of cardiovascular disease. Preventive Medicine, 29, 535-548.
65. Nunes, E. V., Frank, K. A., & Kornfeld, D. S. (1987). Psychologic treatment for the Type A behavior pattern and for coronary heart disease: A meta-analysis of the literature. Psychosomatic Medicine, 49, 159-173.
66. Ockene, J. K., & Zapka, J. G. (1997). Physician-based smoking intervention: A rededication to a five-step strategy to smoking research. Addictive Behaviors, 22, 835-848.
67. Oldridge, N. B. (1984). Compliance and dropout in cardiac exercise rehabilitation. Journal of Cardiac Rehabilitation, 4, 166-177.
68. Oldridge, N. B., Guyatt, G. H., Fischer, M. E., & Rimm, A. A. (1988). Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA, 260, 945-950.
69. Ornish, D. M., Brown, S. E., Scherwitz, L. W., Billings, J. H., Armstrong, W. T., Ports, T. A., et al. (1990a). Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet, 336, 129-133.
70. Ornish, D. M., Brown, S. E., Scherwitz, L. W., Billings, J. H., Armstrong, W. T., Ports, T. A., et al. (1990b). Lifestyle changes and heart disease. Lancet, 336, 741-742.
71. Orth-Gomer, K., & Uniden, A. L. (1990). Type A behavior, social support, and coronary risk: Interactions and significance for mortality in cardiac patients. Psychosomatic Medicine, 52, 9-72.
72. Powell, L. H. (1996). The hook: A metaphor for gaining control of emotional reactivity. In R. Allan & S. Scheidt (Eds.), Heart and mind: The practice of cardiac psychology. Washington, DC: APA.
73. Radloff, L. S. (1977). The CES-D Scale: A self-report depressive scale for research in the general population. Journal of Applied Psychological Measurement, 1, 385-401.
74. Ramm, C., Robinson, S., & Sharpe, N. (2001). Factors determining nonattendance at a cardiac rehabilitation programme following myocardial infarction. New Zealand Medical Journal, 114, 227-229.
75. Roccella, E. J., & Horan, M. J. (1988). The National High Blood Pressure Education Program: Measuring progress and assessing its impact. Health Psychology, 7, 297-303.
76. Roose, S. P., & Spatz, E. (1999). Treatment of depression in patients with heart disease. Journal of Clinical Psychiatry, 60, 34-37.
77. Rosenman, R. H., Swan, G. E., & Carmelli, D. (1988). Definition, assessment, and evolution of the Type A behavior pattern. In B. K. Houston & C. R. Snyder (Eds.), Type A behavior pattern: Research theory and intervention (pp. 8-31). New York: John Wiley.
78. Scandinavian Simvastatin Survival Study 4. (1994). Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study. Lancet, 344, 1383-1389.
79. Scheidt, S. (2000). The current status of heart-mind relationships. Journal of Psychosomatic Research, 48, 317-320.
80. Schlundt, D. G., Mushi, C., Larson, C. O., & Marrs, M. (2001). Use of innovative technologies in the evaluation of Nashville's REACH 2010 community action plan: Reducing disparities in the African American community. Journal of Ambulatory Care Management, 24, 51-60.
81. Sebregts, E. H. W. J., Falger, P. R. J., & Bar, F. W. H. M. (2000). Risk factor modification through nonpharmacological interventions in patients with coronary heart disease. Journal of Psychosomatic Research, 48, 425-441.
82. Sempos, C. T., Cleeman, J. I., Carroll, M. D., Johnson, C. L., Bachorik, P. S., Gordon, D. J., et al. (1993). Prevalence of high blood cholesterol among U.S. adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA, 269, 3009-3014.
83. Shekelle, R. B., Hulley, S. B., Neaton, J. D., Billings, J. H., Borhani, N. O., Gerace, T. A., et al. (1985). The MRFIT Behavior Pattern Study II: Type A behavior and incidence of coronary heart death. American Journal of Epidemiology, 122, 559-570.
84. Shepherd, J. (1995). The West of Scotland Coronary Prevention Study: A trial of cholesterol reduction in Scottish men. American Journal of Cardiology, 76, 113C-117C.
85. Shepherd, J. (1996). The West of Scotland Coronary Prevention Study (WOSCOPS): Benefits of pravastatin therapy in compliant subjects. Circulation, 94, 539-543.
86. Siegler, I. C., Peterson, B. L., Barefoot, J. C., & Williams, R. B. (1992). Hostility during late adolescence predicts coronary risk factors at midlife. American Journal of Epidemiology, 136, 146-154.
87. Simchen, E., Naveh, I., Zitser-Gurevich, Y., Brown, D., & Galai, N. (2001). Is participation in cardiac rehabilitation programs associated with better quality of life and return to work after coronary artery bypass operations? The Israeli CABG Study. Israel Medical Association Journal, 3, 399-403.
88. Smith, T. W., Sanders, J. D., & Alexander, J. F. (1990). What does the cook and medley hostility scale measure? Affect, behavior, and attributions in the marital context. Journal of Personality and Social Psychology, 58, 699-708.
89. Spitzer, R. L., Williams, J. B., Kroenke, K., Linzer, M., deGruy, F. V., III, Hahn, S. R., et al. (1994). Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. JAMA, 272(22), 1749-1756.
90. Steinberg, M. D., & Gotto, A. M. (1999). Preventing coronary artery disease by lowering cholesterol levels. JAMA, 282, 2043-2050.
91. Styne, D. M. (2001). Childhood and adolescent obesity. Prevalence and significance. Pediatric Clinics of North America, 48, 823-854.
92. Sundquist, J., Winkleby, M. A., & Pudaric, S. (2001). Cardiovascular disease risk factors among older Black, Mexican American, and White women and men: An analysis of NHANES III, 1988-1994. Journal of the American Geriatric Society, 49, 109-116.
93. Tate, D. F., Wing, R. R., & Winett, R. A. (2001). Using Internet technology to deliver a behavioral weight loss program. JAMA, 285, 1172-1177.
94. Topol, E. J. (2000). Cleveland Clinic heart book. New York: Hyperion.
95. Waters, D. D. (2001). Are we aggressive enough in lowering cholesterol? American Journal of Cardiology, 88(Suppl. 4), 10F-15F.
96. Watts, G. F., Lewis, B., Brunt, J. N. H., Lewis, E. S., Coltart, D. J., & Smith, L. D. R. (1992). Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet, 339, 563-569.
97. Wee, C. C., McCarthy, E. P., Davis, R. B., & Phillips, R. S. (1999). Physician counseling about exercise. JAMA, 282, 1583-1588.
98. Whiteley, J., & Winett, R. (2001). An Internet-based walking program for women. Unpublished doctoral dissertation, Virginia Polytechnic Institute and State University, Blacksburg.
99. Yoshida, T., Yoshida, K., Yamamoto, C., Nagasaka, M., Tadaura, H., Meguro, T., et al. (2001). Effects of a 2-week, hospitalized phase II cardiac rehabilitation program on physical capacity, lipid profiles, and psychological variables in patients with acute myocardial infarction. Japanese Circulation Journal, 65, 87-93.